Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type Interaction Map description Network Comparison Type Rank Gene Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1575 to 1624 of 3228 in total 
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
m-phase inducer phosphatase 1 (ec 3.1.3.48) (dual specificity phosphatase cdc25a). [source:swissprot;acc:p30304]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1896\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4521\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4805.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06285\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
m-phase inducer phosphatase 2 (ec 3.1.3.48) (dual specificity phosphatase cdc25b). [source:swissprot;acc:p30305]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1989\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4383.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4642.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05922\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
m-phase inducer phosphatase 3 (ec 3.1.3.48) (dual specificity phosphatase cdc25c). [source:swissprot;acc:p30307]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1940\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4450.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4721.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06094\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mab-21-like protein 1; mab-21-like 1. [source:refseq;acc:nm\_005584]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2786\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
mab-21-like protein 2; mab-21-like 2. [source:refseq;acc:nm\_006439]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2783\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mad protein (max dimerizer). [source:swissprot;acc:q05195]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
174\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4455.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5774.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.2958\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mago nashi protein homolog. [source:swissprot;acc:p50606]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2864\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
maguk p55 subfamily member 2 (mpp2 protein) (discs, large homolog 2). [source:swissprot;acc:q14168]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2101\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5241.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5529.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05493\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
maguk p55 subfamily member 3 (mpp3 protein) (discs, large homolog 3). [source:swissprot;acc:q13368]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
987\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6660.04\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7301.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09636\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
maguk p55 subfamily member 6 (veli-associated maguk 1) (vam-1). [source:swissprot;acc:q9nzw5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2091\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5247.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5537.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05526\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
major centromere autoantigen b (centromere protein b) (cenp-b). [source:swissprot;acc:p07199]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3013\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
malate dehydrogenase, cytoplasmic (ec 1.1.1.37). [source:swissprot;acc:p40925]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3213\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
malate dehydrogenase, mitochondrial precursor (ec 1.1.1.37). [source:swissprot;acc:p40926]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2400\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4368.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4539.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03912\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
maleylacetoacetate isomerase (ec 5.2.1.2) (maai) (glutathione s- transferase zeta 1) (ec 2.5.1.18) (gstz1-1). [source:swissprot;acc:o43708]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2486\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3626.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3734.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0299\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
malonyl-coa decarboxylase, mitochondrial precursor (ec 4.1.1.9) (mcd). [source:swissprot;acc:o95822]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1604\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6176.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6617.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07141\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mam domain containing glycosylphosphatidylinositol anchor 1; glycosyl-phosphatidyl-inositol-mam. [source:refseq;acc:nm\_153487]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3070\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mannose-6-phosphate isomerase (ec 5.3.1.8) (phosphomannose isomerase) (pmi) (phosphohexomutase). [source:swissprot;acc:p34949]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1719\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5458.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5830.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06827\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mannose-p-dolichol utilization defect 1 protein (suppressor of lec15 and lec35 glycosylation mutation homolog) (sl15). [source:swissprot;acc:o75352]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
884\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5167.15\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5695.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10224\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mannosyl-oligosaccharide 1,2-alpha-mannosidase ib (ec 3.2.1.113) (processing alpha-1,2-mannosidase ib) (alpha-1,2-mannosidase ib) (mannosidase alpha class 1a member 2). [source:swissprot;acc:o60476]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
220\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24361\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
map kinase-activated protein kinase 2 (ec 2.7.1.-) (mapk-activated protein kinase 2) (mapkap kinase 2) (mapkapk-2). [source:swissprot;acc:p49137]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
475\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9649.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11053.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14549\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
map/microtubule affinity-regulating kinase 1. [source:refseq;acc:nm\_018650]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2586\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4180.32\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4253.46\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0175\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
map/microtubule affinity-regulating kinase 2 isoform b; elkl motif kinase 1; elkl motif kinase. [source:refseq;acc:nm\_004954]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2587\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
maspin precursor (protease inhibitor 5). [source:swissprot;acc:p36952]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2405\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5078.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5275.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03884\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mast cell carboxypeptidase a precursor (ec 3.4.17.1) (mc-cpa) (carboxypeptidase a3). [source:swissprot;acc:p15088]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
240\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7711.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6265.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.23071\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mawd binding protein (unknown protein 32 from 2d-page of liver tissue). [source:swissprot;acc:p30039]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2018\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6555.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6938.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05849\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
max dimerization protein 3; likely ortholog of mouse max dimerization protein 3. [source:refseq;acc:nm\_031300]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
177\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4457.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5773.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.29539\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
max interacting protein 1 (mxi1 protein). [source:swissprot;acc:p50539]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
175\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4456.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5773.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.29553\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
max protein. [source:swissprot;acc:p25912]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
242\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4640.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5704.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.22943\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
max-interacting transcriptional repressor mad4 (max-associated protein 4) (max dimerization protein 4). [source:swissprot;acc:q14582]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
176\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4456.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5773.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.29544\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mbd2 (methyl-cpg-binding protein)-interacting zinc finger protein. [source:refseq;acc:nm\_015517]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1044\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4757.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5198.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09279\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
mct-1 protein. [source:refseq;acc:nm\_014060]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2646\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4778.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4732.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00975\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
megf10 protein. [source:refseq;acc:nm\_032446]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1367\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5793.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6248.71\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07858\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
megf11 protein. [source:refseq;acc:nm\_032445]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1366\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5793.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6248.79\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
megf6 (fragment). [source:sptrembl;acc:o75095]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1338\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5980.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6457.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07978\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
megsin (tp55) (serpin b7). [source:swissprot;acc:o75635]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1688\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5767.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6165.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06904\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
meiotic recombination protein dmc1/lim15 homolog. [source:swissprot;acc:q14565]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1208\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5913.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6423.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08628\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
meiotic recombination protein spo11. [source:swissprot;acc:q9y5k1]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2588\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4180.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4253.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0175\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
melanoma antigen p15 (melanoma-associated antigen recognized by t lymphocytes). [source:swissprot;acc:q13084]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2727\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5603.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5583.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00351\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
melanoma antigen recognized by t cells 2. [source:refseq;acc:nm\_018194]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1914\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6858.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7287.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06246\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
melanoma antigen, family b, 6. [source:refseq;acc:nm\_173523]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
162\vspace{3pt}}&\multirow{11}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
23693.7\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
18263\vspace{3pt}}}&\multirow{11}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.29736\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
melanoma antigen, family d, 4 isoform 1; mage1 protein; mage-e1 protein; maged4 protein. [source:refseq;acc:nm\_030801]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
152\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
melanoma-associated antigen 1 (mage-1 antigen) (antigen mz2-e). [source:swissprot;acc:p43355]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
168\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
melanoma-associated antigen 10 (mage-10 antigen). [source:swissprot;acc:p43363]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
169\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
melanoma-associated antigen 11 (mage-11 antigen). [source:swissprot;acc:p43364]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
155\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
melanoma-associated antigen 12 (mage-12 antigen) (mage12f). [source:swissprot;acc:p43365]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
167\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
melanoma-associated antigen 2 (mage-2 antigen). [source:swissprot;acc:p43356]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
156\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
melanoma-associated antigen 3 (mage-3 antigen) (antigen mz2-d). [source:swissprot;acc:p43357]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
154\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
melanoma-associated antigen 4 (mage-4 antigen) (mage-x2) (mage-41). [source:swissprot;acc:p43358]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
163\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
melanoma-associated antigen 6 (mage-6 antigen) (mage3b). [source:swissprot;acc:p43360]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
158\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
melanoma-associated antigen 8 (mage-8 antigen). [source:swissprot;acc:p43361]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
165\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/